Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-03

Clinical Trial Update: Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)

View source ↗

Summary

Dexcom announced a real-world global registry study evaluating its Continuous Glucose Monitoring System in people with diabetes, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexcom Continuous Glucose Monitoring System

Snippet

Sponsor: DexCom, Inc. | Conditions: Diabetes | Status: RECRUITING